TECH

BIO-TECHNE CORP

Healthcare | Mid Cap

$0.49

EPS Forecast

$319

Revenue Forecast

Announcing earnings for the quarter ending 2025-06-30 soon
CRSPCrispr Therapeutics AgHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncREPLReplimune Group IncRGENRepligen CorpNVAXNovavax IncMRNAModerna IncDNLIDenali Therapeutics Inc